Obesity and Triple-Negative Breast Cancer: Disparities, Controversies, and Biology
Overview
Affiliations
Once considered a problem of Western nations, obesity (body mass index ≥30 kg/m) has rapidly increased since the 1970s to become a major threat to world health. Since 1970, the face of obesity has changed from a disease of affluence and abundance to a disease of poverty. During the last 10 years, studies have mechanistically linked obesity and an obese tumor microenvironment with signaling pathways that predict aggressive breast cancer biology. For example, in the United States, African American women are more likely than non-Hispanic European American women to be obese and to be diagnosed with triple-negative breast cancer (TNBC). In 2008, the Carolina Breast Study found that obesity (increased waist/hip ratio) was linked to an increased incidence of TNBC in premenopausal and postmenopausal African American women. Subsequently, several groups have investigated the potential link between obesity and TNBC in African American women. To date, the data are complex and sometimes contradictory. We review epidemiologic studies that investigated the potential association among obesity, metabolic syndrome, and TNBC in African American women and mechanistic studies that link insulin signaling to the obese breast microenvironment, tissue inflammation, and aggressive TNBC biology.
Insulin resistance and cancer: molecular links and clinical perspectives.
Caturano A, Erul E, Nilo R, Nilo D, Russo V, Rinaldi L Mol Cell Biochem. 2025; .
PMID: 40089612 DOI: 10.1007/s11010-025-05245-8.
Obesity increases DNA damage in the breast epithelium.
Gaber M, Quentel A, Holmes J, Lepetit C, Triki H, Wilson A Breast Cancer Res. 2025; 27(1):11.
PMID: 39838489 PMC: 11753040. DOI: 10.1186/s13058-025-01961-7.
Weight-adjusted-waist index: an innovative indicator of breast cancer hazard.
Huang X, Cheng H, Deng L, Wang S, Li J, Qin A BMC Womens Health. 2024; 24(1):660.
PMID: 39709439 PMC: 11663314. DOI: 10.1186/s12905-024-03507-z.
Randolph L, Joshi J, Sanchez A, Pratap U, Gopalam R, Chen Y Cancers (Basel). 2024; 16(21).
PMID: 39518071 PMC: 11545110. DOI: 10.3390/cancers16213630.
Macrophages: Key Players in the Battle against Triple-Negative Breast Cancer.
Padzinska-Pruszynska I, Kucharzewska P, Matejuk A, Gorczak M, Kubiak M, Taciak B Int J Mol Sci. 2024; 25(19).
PMID: 39409110 PMC: 11476577. DOI: 10.3390/ijms251910781.